CompletedNot Applicable

Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)

France611 participantsStarted 2017-02-28

Plain-language summary

The GASTROVIM research explores the links between individual genetic susceptibility, genetic variability of rotavirus strains and effectiveness of immunization with the rotavirus vaccination: a clinical investigation to assess glycan attachment specificity, toward rotavirus vaccine improvement.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 0 to 16. * giving consent to participate if applicable (\>6yo) * Parents informed and written consent obtained * admitted in paediatric emergency for wether an acute gastroenteritis (case group) or anything else than an infection or gastroenteritis (control group) Exclusion Criteria: * case group: rotavirus rapid screen test negative; viral gastroenteritis other than rotavirus; bacterial gastroenteritis * control group: Family and / or patient unable to full informed consent to research; Infectious Pathology context in general.

What they're measuring

Absence / Presence of non-secretory polymorphisms FUT2- and Lewis Negative FUT3-

Timeframe: 6 months after inclusion

Trial details

NCT IDNCT02902445

SponsorNantes University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-10-15

View on ClinicalTrials.gov More Gastroenteritis trials